Dennis GJ - Search Results

1

Development of autoantibodies before the clinical onset of systemic lupus erythematosus.

Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, Harley JB. Arbuckle MR, et al. Among authors: dennis gj. N Engl J Med. 2003 Oct 16;349(16):1526-33. doi: 10.1056/NEJMoa021933. N Engl J Med. 2003. PMID: 14561795 Free article.

2

The prevalence, onset, and clinical significance of antiphospholipid antibodies prior to diagnosis of systemic lupus erythematosus.

McClain MT, Arbuckle MR, Heinlen LD, Dennis GJ, Roebuck J, Rubertone MV, Harley JB, James JA. McClain MT, et al. Among authors: dennis gj. Arthritis Rheum. 2004 Apr;50(4):1226-32. doi: 10.1002/art.20120. Arthritis Rheum. 2004. PMID: 15077305 Free article.

3

Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry.

McClain MT, Heinlen LD, Dennis GJ, Roebuck J, Harley JB, James JA. McClain MT, et al. Among authors: dennis gj. Nat Med. 2005 Jan;11(1):85-9. doi: 10.1038/nm1167. Epub 2004 Dec 26. Nat Med. 2005. PMID: 15619631

4

Development of anti-dsDNA autoantibodies prior to clinical diagnosis of systemic lupus erythematosus.

Arbuckle MR, James JA, Kohlhase KF, Rubertone MV, Dennis GJ, Harley JB. Arbuckle MR, et al. Among authors: dennis gj. Scand J Immunol. 2001 Jul-Aug;54(1-2):211-9. doi: 10.1046/j.1365-3083.2001.00959.x. Scand J Immunol. 2001. PMID: 11439169 Free article.

5

Rapid clinical progression to diagnosis among African-American men with systemic lupus erythematosus.

Arbuckle MR, James JA, Dennis GJ, Rubertone MV, McClain MT, Kim XR, Harley JB. Arbuckle MR, et al. Among authors: dennis gj. Lupus. 2003;12(2):99-106. doi: 10.1191/0961203303lu334oa. Lupus. 2003. PMID: 12630753

6

Hydroxychloroquine sulfate treatment is associated with later onset of systemic lupus erythematosus.

James JA, Kim-Howard XR, Bruner BF, Jonsson MK, McClain MT, Arbuckle MR, Walker C, Dennis GJ, Merrill JT, Harley JB. James JA, et al. Among authors: dennis gj. Lupus. 2007;16(6):401-9. doi: 10.1177/0961203307078579. Lupus. 2007. PMID: 17664230

7

Impact of early versus late systemic lupus erythematosus diagnosis on clinical and economic outcomes.

Oglesby A, Korves C, Laliberté F, Dennis G, Rao S, Suthoff ED, Wei R, Duh MS. Oglesby A, et al. Appl Health Econ Health Policy. 2014 Apr;12(2):179-90. doi: 10.1007/s40258-014-0085-x. Appl Health Econ Health Policy. 2014. PMID: 24573911

8

Belimumab: a BLyS-specific inhibitor for the treatment of systemic lupus erythematosus.

Dennis GJ. Dennis GJ. Clin Pharmacol Ther. 2012 Jan;91(1):143-9. doi: 10.1038/clpt.2011.290. Epub 2011 Nov 30. Clin Pharmacol Ther. 2012. PMID: 22130121 Review.

9

Healthcare utilization and cost of systemic lupus erythematosus in a US managed care health plan.

Garris C, Jhingran P, Bass D, Engel-Nitz NM, Riedel A, Dennis G. Garris C, et al. J Med Econ. 2013;16(5):667-77. doi: 10.3111/13696998.2013.778270. Epub 2013 Mar 11. J Med Econ. 2013. PMID: 23425294 Free article.

10

Antibodies against p53 in sera from patients with systemic lupus erythematosus and other rheumatic diseases.

Kovacs B, Patel A, Hershey JN, Dennis GJ, Kirschfink M, Tsokos GC. Kovacs B, et al. Among authors: dennis gj. Arthritis Rheum. 1997 May;40(5):980-2. doi: 10.1002/art.1780400531. Arthritis Rheum. 1997. PMID: 9153564 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters